We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Corporate Antietam

8 March 2007 By Rob Cox

Even with a third bump, the $26bn company s investors are faced with a CVS takeover offer that s below the current stock price. But the alternative doesn t look good. It s not just that Express s bid has holes Caremark s management will go nuclear to frustrate it.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)